Plasma cells Bone marrow stromal cells Non-Hodgkin lymphoma Acute graft-versus-host disease B cell lymphoma B cell Immune tolerance Stromal cells Follicular lymphoma PD-L1 expression Apoptosis Mesenchymal stromal cells Leukemia Immunomodulation Lenalidomide Massive weight loss Multiple myeloma LGL leukemia Tolerance Acute myeloid leukemia Angiogenesis Flow cytometry CD19 Prognosis Allergy Abdominoplasty Differentiation Standardization Cell therapy Adipose stem cells Multiple sclerosis Belt lipectomy Perforator flap NK cells Biomarqueurs Cancer Activation Immunotherapy Cancer-associated fibroblasts P53 ING2 Biomarker Neutrophils B lymphocyte Macrophages Bodylift Biomarkers Humans Monocyte Follicular dendritic cells Sepsis 3-dioxygenase B-lymphocytes Bariatric surgery Breast Cancer ING1 Allorecognition Bispecific antibodies MDSC Septic shock Relapse Rituximab B cell differentiation B-cells Follicular helper T cells Nivolumab Large granular lymphocyte leukemia Ibrutinib Lymphocytes B-cell lymphoma Bioinformatics Pregnancy Checkpoint inhibitors Acquired infections TRAIL 18F-FDG PET Lymphocytes B Transplantation Primary CNS lymphoma Mesenchymal stem cells Germinal center Mass cytometry CAR T-cells Anti-PD1 Tumor microenvironment Monocytes DNA methylation Immunosuppression Hodgkin lymphoma CAR-T cells Fibroblastic reticular cells CXCR4 Arginine Myeloid-derived suppressor cells COVID-19 B cells Lymphoma Autologous gluteal augmentation Microenvironment Bone marrow